INTERNATIONAL GUIDE TO DRUGS FOR PARKINSONS-DISEASE

被引：19

作者：

OERTEL, WH

DODEL, RC

机构：

[1] Department of Neurology, Ludwig-Maximilians-University, Munich, Klinikum Grosshadern

来源：

MOVEMENT DISORDERS | 1995年 / 10卷 / 02期

关键词：

INTERNATIONAL DRUG GUIDE; PARKINSONS DISEASE;

D O I：

10.1002/mds.870100202

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Pharmacotherapy of Parkinson's disease (PD) has become so effective that patients with PD can enjoy a nearly normal life, including travel for several years. The degree of international travel of patients with PD and in particular the recent increased coordination between health systems in the European community call for a detailed information on the different antiparkinsonian drugs available worldwide. To provide an overview for physicians and patients on the diversity of preparations available in the different countries, we compiled the most commonly used substances along with their size of dosage and formula in an international guide to drugs for PD.

引用

页码：121 / 131

页数：11

共 22 条

[1]

BILLUPS NF, 1993, AM DRUG INDEX

[2]

BIRKMAYER W, 1961, Wien Klin Wochenschr, V73, P787

[3]

CALNE DB, 1993, NEW ENGL J MED, V329, P1021

[4] MODIFICATION OF PARKINSONISM - CHRONIC TREATMENT WITH L-DOPA [J].

COTZIAS, GC ;

PAPAVASI.PS ;

GELLENE, R .

NEW ENGLAND JOURNAL OF MEDICINE, 1969, 280 (07) :337-&

[5]

Fahn S., 1989, MOV DISORD S1, V4, P2

[6] THE MANAGEMENT OF THE LEVODOPA PSYCHOSES [J].

FRIEDMAN, JH .

CLINICAL NEUROPHARMACOLOGY, 1991, 14 (04) :283-295

[7]

KLINGLER D, 1986, WIEN KLIN WOCHENSCHR, V15, P399

[8]

Marsden C.D., 1982, MOVEMENT DISORD, P96

[9] PARKINSONS-DISEASE [J].

MARSDEN, CD .

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1994, 57 (06) :672-681

[10]

OBESO JA, 1989, MOV DISORD S1, V4, P70

← 1 2 3 →